Form D — BioLattice Ophthalmics, Inc,
0002125596-26-000001 · filed Mar 30, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,500,000
- Reported amount sold
- $575,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BioLattice Ophthalmics, Inc,
- CIK
- 2125596
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 2929 Arch Street
Philadelphia, Pennsylvania 19104 - Phone
- 267 481 5423
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Linda Alunkal · Executive OfficerPhiladelphia, Pennsylvania Find on LinkedIn ↗
-
Amelia Zellander · Executive OfficerPhiladelphia, Pennsylvania Find on LinkedIn ↗
-
Gregory Jackson · DirectorPhiladelphia, Pennsylvania Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗